| UniProt ID | IL1AP_MOUSE | |
|---|---|---|
| UniProt AC | Q61730 | |
| Protein Name | Interleukin-1 receptor accessory protein | |
| Gene Name | Il1rap | |
| Organism | Mus musculus (Mouse). | |
| Sequence Length | 570 | |
| Subcellular Localization |
Isoform 1: Cell membrane Single-pass type I membrane protein. Isoform 2: Secreted. |
|
| Protein Description | Coreceptor for IL1RL2 in the IL-36 signaling system. Coreceptor with IL1R1 in the IL-1 signaling system. Associates with IL1R1 bound to IL1B to form the high affinity interleukin-1 receptor complex which mediates interleukin-1-dependent activation of NF-kappa-B and other pathways. Signaling involves the recruitment of adapter molecules such as TOLLIP, MYD88, and IRAK1 or IRAK2 via the respective TIR domains of the receptor/coreceptor subunits. Recruits TOLLIP to the signaling complex. Does not bind to interleukin-1 alone; binding of IL1RN to IL1R1, prevents its association with IL1R1 to form a signaling complex. The cellular response is modulated through a non-signaling association with the membrane IL1R2 decoy receptor. Secreted forms (isoforms 2 and 3) associate with secreted ligand-bound IL1R2 and increase the affinity of secreted IL1R2 for IL1B; this complex formation may be the dominant mechanism for neutralization of IL1B by secreted/soluble receptors. Coreceptor for IL1RL1 in the IL-33 signaling system. Can bidirectionally induce pre- and postsynaptic differentiation of neurons by trans-synaptically binding to PTPRD. [PubMed: 25908590 May play a role in IL1B-mediated costimulation of IFNG production from T-helper 1 (Th1) cells (By similarity; Isoform 2: Associates with secreted ligand-bound IL1R2 and increases the affinity of secreted IL1R2 for IL1B; this complex formation may be the dominant mechanism for neutralization of IL1B by secreted/soluble receptors. Enhances the ability of secreted IL1R1 to inhibit IL-33 signaling.; Isoform 3: Required for Src phosphorylation by IL1B. Required for IL1B-potentiated NMDA-induced calcium influx in neurons acting in cooperation with IL1R1 isoform 2 to mediate Akt kinase activation.] | |
| Protein Sequence | MGLLWYLMSLSFYGILQSHASERCDDWGLDTMRQIQVFEDEPARIKCPLFEHFLKYNYSTAHSSGLTLIWYWTRQDRDLEEPINFRLPENRISKEKDVLWFRPTLLNDTGNYTCMLRNTTYCSKVAFPLEVVQKDSCFNSAMRFPVHKMYIEHGIHKITCPNVDGYFPSSVKPSVTWYKGCTEIVDFHNVLPEGMNLSFFIPLVSNNGNYTCVVTYPENGRLFHLTRTVTVKVVGSPKDALPPQIYSPNDRVVYEKEPGEELVIPCKVYFSFIMDSHNEVWWTIDGKKPDDVTVDITINESVSYSSTEDETRTQILSIKKVTPEDLRRNYVCHARNTKGEAEQAAKVKQKVIPPRYTVELACGFGATVFLVVVLIVVYHVYWLEMVLFYRAHFGTDETILDGKEYDIYVSYARNVEEEEFVLLTLRGVLENEFGYKLCIFDRDSLPGGIVTDETLSFIQKSRRLLVVLSPNYVLQGTQALLELKAGLENMASRGNINVILVQYKAVKDMKVKELKRAKTVLTVIKWKGEKSKYPQGRFWKQLQVAMPVKKSPRWSSNDKQGLSYSSLKNV | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 57 | N-linked_Glycosylation | FEHFLKYNYSTAHSS HHHHHHCCHHHHCCC | 23.77 | 25908590 | |
| 107 | N-linked_Glycosylation | WFRPTLLNDTGNYTC EECCCCCCCCCCEEE | 48.16 | 25908590 | |
| 111 | N-linked_Glycosylation | TLLNDTGNYTCMLRN CCCCCCCCEEEEEEC | 30.91 | 25908590 | |
| 118 | N-linked_Glycosylation | NYTCMLRNTTYCSKV CEEEEEECCCCCCEE | 32.58 | 25908590 | |
| 196 | N-linked_Glycosylation | NVLPEGMNLSFFIPL HCCCCCCCEEEEEEE | 43.31 | - | |
| 209 | N-linked_Glycosylation | PLVSNNGNYTCVVTY EEEECCCCEEEEEEE | 30.94 | 25908590 | |
| 299 | N-linked_Glycosylation | VTVDITINESVSYSS EEEEEEECCCCCCCC | 27.17 | - | |
| 395 | Phosphorylation | FYRAHFGTDETILDG HHHHHHCCCCEECCC | 29.71 | 17622165 | |
| 398 | Phosphorylation | AHFGTDETILDGKEY HHHCCCCEECCCCEE | 29.65 | 17622165 | |
| 540 | Ubiquitination | YPQGRFWKQLQVAMP CCCCCHHEEEEEEEE | 38.12 | - | |
| 555 | Phosphorylation | VKKSPRWSSNDKQGL CCCCCCCCCCCCCCC | 22.12 | 26745281 | |
| 556 | Phosphorylation | KKSPRWSSNDKQGLS CCCCCCCCCCCCCCC | 41.93 | 26745281 | |
| 559 | Ubiquitination | PRWSSNDKQGLSYSS CCCCCCCCCCCCHHH | 50.98 | 22790023 | |
| 563 | Phosphorylation | SNDKQGLSYSSLKNV CCCCCCCCHHHCCCC | 29.78 | 29472430 | |
| 564 | Phosphorylation | NDKQGLSYSSLKNV- CCCCCCCHHHCCCC- | 13.81 | 29514104 | |
| 565 | Phosphorylation | DKQGLSYSSLKNV-- CCCCCCHHHCCCC-- | 26.31 | 26745281 | |
| 566 | Phosphorylation | KQGLSYSSLKNV--- CCCCCHHHCCCC--- | 34.82 | 27600695 | |
| 584 (in isoform 3) | Phosphorylation | - | 29899451 | ||
| 589 (in isoform 3) | Phosphorylation | - | - | ||
| 589 | Phosphorylation | -------------------------- -------------------------- | - | ||
| 589 | Phosphorylation | -------------------------- -------------------------- | - | ||
| 597 (in isoform 3) | Phosphorylation | - | - | ||
| 597 | Phosphorylation | ---------------------------------- ---------------------------------- | - | ||
| 597 | Phosphorylation | ---------------------------------- ---------------------------------- | - | ||
| 599 (in isoform 3) | Phosphorylation | - | - | ||
| 599 | Phosphorylation | ------------------------------------ ------------------------------------ | - | ||
| 599 | Phosphorylation | ------------------------------------ ------------------------------------ | - |
| Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
|---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of IL1AP_MOUSE !! | ||||||
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of IL1AP_MOUSE !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of IL1AP_MOUSE !! | ||||||
| Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
|---|---|---|---|---|
| MYD88_HUMAN | MYD88 | physical | 11880380 | |
| IRAK1_MOUSE | Irak1 | physical | 18562480 |
| Kegg Drug | ||||||
|---|---|---|---|---|---|---|
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| Phosphorylation | |
| Reference | PubMed |
| "A differential phosphoproteomic analysis of retinoic acid-treated P19cells."; Smith J.C., Duchesne M.A., Tozzi P., Ethier M., Figeys D.; J. Proteome Res. 6:3174-3186(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-395 AND THR-398, ANDMASS SPECTROMETRY. | |